Medication
-
Professor Gabrielle Carlson
Gabrielle Carlson is Professor of Psychiatry and Pediatrics at Renaissance School of Medicine at Stony Brook University. She is also President of AACAP (American Academy of Child & Adolescent Psychiatry) Professor Carlson is a Joint Editor of CAMH.
Read more -
Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial
Paper from the JCPP – ‘Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulties in social communication and interaction. Crucial for efficient social interaction is the ability to quickly and accurately extract information from a person’s face.’ Matthijs Moerkerke (pic) et al.
Read more -
Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
Open Access paper from the JCPP – This study aimed to assess whether age of onset and duration of stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) are associated with cocaine, methamphetamine, and prescription stimulant misuse during adolescence. Sean Esteban McCabe (pic) et al.
Read more -
Editorial Perspective: When to start de-implementation of interventions: the case of cognitive training for children with ADHD
Open Access paper from the JCPP – “The picture is clear that the large majority of the cognitive training paradigms that are currently being distributed commercially for children with ADHD on a large scale are not backed-up by a sufficient evidence base. This does not suggest that further treatment development research is not warranted as we believe that this line of research may one day lead to effective treatments.” Tycho J. Dekkers (pic) and Saskia van der Oord
Read more -
‘NDC Learning Series’ – Medications and Physical Health recording
We welcomed Dr. Mark Lovell and Dr. Max Davie. with a session that will focus on ‘Medications and Physical Health’. The Chair of this session was Dr. Ann Ozsivadjian. This was the fifth, of the ‘NDC Learning Series’ aimed at health professionals who come into contact with children and young people who have Neurodevelopmental conditions (NDCs).
Read more -
‘NDC Learning Series’ – Medications and Physical Health recording (members)
We welcomed Dr. Mark Lovell and Dr. Max Davie. with a session that will focus on ‘Medications and Physical Health’. The Chair of this session was Dr. Ann Ozsivadjian. This was the fifth, of the ‘NDC Learning Series’ aimed at health professionals who come into contact with children and young people who have Neurodevelopmental conditions (NDCs). ACAMH members can now receive a CPD certificate for watching this recorded lecture.
Read more -
January 2021 – The Bridge
This issue of The Bridge features summaries of recent child and adolescent mental health research. I hope you enjoy reading about this excellent work which improves our understanding of a wide range of conditions and informs mental health care for young people.
Read more -
Access to evidence-based behavioural interventions needs improving for children affected by Tics
In 2016, Chris Hollis and colleagues compiled a Practitioner Review for the Journal of Child Psychology and Psychiatry evaluating the most effective and well-supported interventions for children and young people affected by Tourette syndrome and chronic tic disorder. Here, they discuss the key findings from their systematic review, and highlight that children and young people affected by tics require improved access to evidence-based behavioural interventions.
Read more -
Sleep Edition
This edition of The Bridge concentrates on sleep, a poignant reminder that I am editing this on a 6am train to London having shortened my own sleep cycle and feeling rather sleep deprived on this dark winter morning.
Read more -
Prescribing in the dark: off-label drug treatments for children with insomnia
Insomnia is a common problem in children with neurodevelopmental disabilities (NDDs), and has a profound effect on quality-of-life.
Read more